Aspirin for primary prevention of vascular disease in people with diabetes.

Aspirin for primary prevention of vascular disease in people with diabetes.

Chi tiết về thư mục
Những tác giả chính:	Haynes, R, Bowman, L, Armitage, J
Định dạng:	Journal article
Ngôn ngữ:	English
Được phát hành:	2009

Những quyển sách tương tự

Aspirin in the primary prevention of vascular disease Reply
Bằng: Baigent, C, et al.
Được phát hành: (2009)

Aspirin in the primary prevention of vascular disease Reply
Bằng: Baigent, C, et al.
Được phát hành: (2009)

Effects of aspirin for primary prevention in persons with diabetes mellitus
Bằng: Bowman, L, et al.
Được phát hành: (2018)

Aspirin for primary prevention of cardiovascular disease in diabetes
Bằng: Ying Xing, et al.
Được phát hành: (2019-07-01)

ASCEND: A Study of Cardiovascular Events iN Diabetes: Characteristics of a randomized trial of aspirin and of omega-3 fatty acid supplementation in 15,480 people with diabetes
Bằng: Bowman, L, et al.
Được phát hành: (2017)

Effects of aspirin on dementia and cognitive function in diabetic patients: the ASCEND trial
Bằng: Parish, S, et al.
Được phát hành: (2022)

ASCEND-Eye: effects of aspirin on diabetic retinopathy
Bằng: Sammons, E, et al.
Được phát hành: (2024)

Is clopidogrel superior to aspirin in secondary prevention of vascular disease?
Bằng: Algra Ale, et al.
Được phát hành: (2000-11-01)

Polypills with or without aspirin for primary prevention of cardiovascular disease
Bằng: Mant, J, et al.
Được phát hành: (2021)

Primary prevention of cardiovascular events in diabetes: is there a role for aspirin?
Bằng: Price, H, et al.
Được phát hành: (2009)

Role of aspirin in primary prevention of cardiovascular disease
Bằng: Patrono, C, et al.
Được phát hành: (2019)

Aspirin overutilization for the primary prevention of cardiovascular disease
Bằng: VanWormer JJ, et al.
Được phát hành: (2014-12-01)

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials.
Bằng: Baigent, C, et al.
Được phát hành: (2009)

Aspirin nonsensitivity in patients with vascular disease: Assessment by light transmission aggregometry (aspirin nonsensitivity in vascular patients)
Bằng: Hamzah Khan, et al.
Được phát hành: (2021-12-01)

Aspirin and other antiplatelet agents in the secondary and primary prevention of cardiovascular disease.
Bằng: Hennekens, C, et al.
Được phát hành: (1989)

US population qualifying for aspirin use for primary prevention of cardiovascular disease
Bằng: Athena L. Huang, et al.
Được phát hành: (2024-06-01)

US POPULATION QUALIFYING FOR ASPIRIN USE FOR PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE:
Bằng: Athena L. Huang, MD, et al.
Được phát hành: (2023-09-01)

Use of aspirin for primary and secondary prevention of cardiovascular disease in diabetic patients in an ambulatory care setting in Spain
Bằng: Fernández-de-Bobadilla Jaime, et al.
Được phát hành: (2007-10-01)

Aspirin for prevention of cancer and cardiovascular disease.
Bằng: Rose, P, et al.
Được phát hành: (2011)

Role of aspirin in the primary prevention of cardiovascular disease in patients with hyperlipoproteinaemia(a)
Bằng: Eleni Giannopoulou, et al.
Được phát hành: (2024-12-01)

PREVENTION OF CARDIOVASCULAR COMPLICATIONS IN DIABETES MELLITUS: THE ROLE OF ASPIRIN
Bằng: L. A. Strizhakov
Được phát hành: (2012-04-01)

Prevention. Aspirin in primary prevention--good news and bad news.
Bằng: Hennekens, C, et al.
Được phát hành: (2012)

Prevention: Aspirin in primary prevention-good news and bad news
Bằng: Hennekens, C, et al.
Được phát hành: (2012)

The effect of sarpogrelate compared to aspirin in high- or very-high-risk diabetes for primary prevention
Bằng: Soo Hyun Kang, et al.
Được phát hành: (2025-01-01)

Aspirin for the Primary Prevention of Vascular Ischemic Events: An Updated Systematic Review and Meta-analysis to Support Shared Decision-Making
Bằng: Chloë Laferrière, MD, et al.
Được phát hành: (2023-12-01)

Low-dose aspirin and rivaroxaban combination therapy to overcome aspirin non-sensitivity in patients with vascular disease
Bằng: Hamzah Khan, et al.
Được phát hành: (2022-08-01)

Aspirin for primary prevention of cardiovaascular events: what are the evidances?
Bằng: Yenny Yenny
Được phát hành: (2019-08-01)

6 voices in 10 minutes: Aspirin in primary prevention
Bằng: Carlos Buso
Được phát hành: (2020-11-01)

The Efficacy And Safety Of Aspirin As The Primary Prevention Of Cardiovascular Disease: An Updated Meta-Analysis
Bằng: Xie W, et al.
Được phát hành: (2019-09-01)

CLINICAL SIGNIFICANCE OF ASPIRIN RESISTANCE IN PATIENTS WITH CARDIO-VASCULAR DISEASES
Bằng: P. J. Dovgalevsky, et al.
Được phát hành: (2016-01-01)

ASPIRIN FOR PRIMARY PREVENTION IN HIGH-RISK TYPE 2 DIABETES: INSIGHTS FROM THE ACCORD TRIAL
Bằng: Juliana H. Namutebi, MD, MS
Được phát hành: (2024-09-01)

Prevention of serious vascular events by aspirin amongst patients with peripheral arterial disease: randomized, double-blind trial.
Bằng: Catalano, M, et al.
Được phát hành: (2007)

Assessment of Vascular Event Prevention and Cognitive Function Among Older Adults With Preexisting Vascular Disease or Diabetes: A Secondary Analysis of 3 Randomized Clinical Trials
Bằng: Offer, A, et al.
Được phát hành: (2019)

Once daily low-dose aspirin reduces urinary thromboxane B2 effectively even at 12-24 hours from dosing in the ASCEND (A Study of Cardiovascular Events iN Diabetes) trial
Bằng: Aung, T, et al.
Được phát hành: (2017)

Effect of aspirin on primary prevention of cardiovascular disease and mortality among patients with chronic kidney disease
Bằng: Hadar Haim-Pinhas, et al.
Được phát hành: (2022-10-01)

Underutilization of aspirin persists in US ambulatory care for the secondary and primary prevention of cardiovascular disease.
Được phát hành: (2005-12-01)

Cost‐Effectiveness of a Statewide Campaign to Promote Aspirin Use for Primary Prevention of Cardiovascular Disease
Bằng: Tzeyu L. Michaud, et al.
Được phát hành: (2015-12-01)

ASPIRIN IN THE PREVENTION OF ATHEROTHROMBOSIS AND CORONARY HEART DISEASE
Bằng: M. G. Bubnova
Được phát hành: (2010-08-01)

Aspirin for primary prevention of ST segment elevation myocardial infarction in persons with diabetes and multiple risk factors
Bằng: Raffaele Bugiardini, et al.
Được phát hành: (2020-10-01)

Hospital costs associated with adverse events in people with diabetes in the UK
Bằng: Keng, MJ, et al.
Được phát hành: (2022)